Skip to main content
. 2022 Oct 31;41(7):1383–1392. doi: 10.1200/JCO.22.01226

FIG 2.

FIG 2.

Basic clinical characteristics and level of CTCs for the transplant-ineligible cohort: the level of CTCs, ISS stage, cytogenetic risk, LDH, sex, and median PFS. aSignificantly different distribution between multiple myeloma groups according to Fisher's exact test (Data Supplement). CTC, circulating tumor plasma cell; ISS, International Staging System; LDH, lactate dehydrogenase; PFS, progression-free survival.